MTCR | | Metacrine, Inc. | Klassen Preston | Director | Mar 23, 2023 | Option Exercise | $0.47 | 842,211 | 395,839 | 1,384,116 | Mar 24, 2023, 12:35 PM |
MTCR | | Metacrine, Inc. | Klassen Preston | President & CEO | Jan 26, 2023 | Sale | $0.41 | 380,605 | 157,266 | 541,905 | Jan 27, 2023, 04:42 PM |
MTCR | | Metacrine, Inc. | Klassen Preston | President & CEO | Apr 19, 2022 | Sale | $0.50 | 44,748 | 22,472 | 923,683 | Apr 20, 2022, 04:25 PM |
MTCR | | Metacrine, Inc. | Klassen Preston | President & CEO | May 20, 2021 | Buy | $3.64 | 20,547 | 74,692 | 20,547 | May 20, 2021, 06:55 PM |
ARNA | | ARENA PHARMACEUTICALS INC | Klassen Preston | EVP and CMO | Oct 14, 2019 | Option Exercise | $47.32 | 2,309 | 109,262 | 3,991 | Oct 16, 2019, 08:20 PM |
ARNA | | ARENA PHARMACEUTICALS INC | Klassen Preston | EVP and CMO | Jan 07, 2019 | Sale | $28.40 | 32,000 | 908,666 | 16,000 | Jan 08, 2019, 09:04 PM |
ARNA | | ARENA PHARMACEUTICALS INC | Klassen Preston | EVP and CMO | Jan 08, 2019 | Option Exercise | $29.55 | 6,000 | 177,300 | 3,000 | Jan 08, 2019, 09:04 PM |
OREX | | Orexigen Therapeutics, Inc. | Klassen Preston | EVP, Global Development | May 30, 2015 | Option Exercise | $4.17 | 1,860 | 7,756 | 5,990 | Feb 04, 2016, 12:06 PM |
OREX | | Orexigen Therapeutics, Inc. | Klassen Preston | EVP, Global Development | Nov 30, 2015 | Option Exercise | $2.03 | 4,170 | 8,465 | 10,160 | Feb 04, 2016, 12:06 PM |
OREX | | Orexigen Therapeutics, Inc. | Klassen Preston | SVP, Head Global Development | Nov 28, 2014 | Option Exercise | $4.92 | 1,542 | 7,587 | 4,130 | Feb 05, 2015, 05:32 PM |
OREX | | Orexigen Therapeutics, Inc. | Klassen Preston | SVP, Head Global Development | May 30, 2014 | Option Exercise | $5.25 | 1,318 | 6,920 | 2,588 | Feb 05, 2015, 05:32 PM |
OREX | | Orexigen Therapeutics, Inc. | Klassen Preston | SVP, Head Global Development | Nov 29, 2013 | Option Exercise | $5.34 | 1,270 | 6,782 | 1,270 | Feb 11, 2014, 07:33 AM |
OREX | | Orexigen Therapeutics, Inc. | Klassen Preston | SVP, Head Global Development | Jul 25, 2013 | Option Exercise | $4.41 | 142,458 | 628,240 | 71,229 | Jul 29, 2013, 07:49 PM |
OREX | | Orexigen Therapeutics, Inc. | Klassen Preston | SVP, Head Global Development | May 28, 2013 | Option Exercise | $4.43 | 57,542 | 255,118 | 28,771 | May 30, 2013, 05:38 PM |